Brian C. Broderick’s Vertex Pharmaceuticals VRTX Stock Holding History

Brian C. Broderick’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.33M	Buy	18,656 +1,454	+8%	+$678K	1.54%	24
2025 Q4	$7.8M	Sell	17,202 -49	-0.3%	-$21.1K	1.47%	25
2025 Q3	$6.76M	Sell	17,251 -420	-2%	-$176K	1.28%	29
2025 Q2	$7.87M	Sell	17,671 -330	-2%	-$152K	1.56%	25
2025 Q1	$8.73M	Buy	18,001 +1,127	+7%	+$525K	1.78%	23
2024 Q4	$6.8M	Buy	16,874 +5,414	+47%	+$2.51M	1.33%	27
2024 Q3	$5.33M	Buy	11,460 +3,876	+51%	+$1.86M	1.04%	33
2024 Q2	$3.55M	Buy	7,584 +5,473	+259%	+$2.38M	0.73%	35
2024 Q1	$882K	Buy	+2,111	New	+$892K	0.19%	62

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Brian C. Broderick's VRTX Position: Q1 2026 in Review

Brian C. Broderick increased its Vertex Pharmaceuticals (VRTX) stake by 8.5% in Q1 2026, buying an estimated $678K and bringing the position to 18,656 shares worth $8.33M. The position accounts for 1.54% of the portfolio, ranked #24.

Brian C. Broderick first reported a position in VRTX in Q1 2024 and has held it in 9 quarters since. The position peaked at $8.73M in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Brian C. Broderick held 18,656 shares of Vertex Pharmaceuticals worth $8.33M as of Q1 2026.
Brian C. Broderick bought 1,454 Vertex Pharmaceuticals shares in Q1 2026, an estimated $678K.
Vertex Pharmaceuticals made up 1.54% of Brian C. Broderick's portfolio in Q1 2026, its #24 holding.
Brian C. Broderick first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
Brian C. Broderick's Vertex Pharmaceuticals position peaked at $8.73M in Q1 2025.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Brian C. Broderick's 13F filing for Q1 2026, filed 7 May 2026.